Atrial fibrillation in Europe: state of the state in disease management!

2014 ◽  
Vol 35 (47) ◽  
pp. 3326-3327 ◽  
Author(s):  
J. Pillarisetti ◽  
D. Lakkireddy
Author(s):  
Sidrah Liaqat ◽  
Kia Dashtipour ◽  
Adnan Zahid ◽  
Kamran Arshad ◽  
Sana Ullah Jan ◽  
...  

Atrial fibrillation (AF) is one of the most common types of cardiac arrhythmia, with a prevalence of 1–2% in the community, increasing the risk of stroke and myocardial infarction. Early detection of AF, typically causing an irregular and abnormally fast heart rate, can help reduce the risk of strokes that are more common among older people. Intelligent models capable of automatic detection of AF in its earliest possible stages can improve the early diagnosis and treatment. Luckily, this can be made possible with the information about the heart's rhythm and electrical activity provided through electrocardiogram (ECG) and the decision-making machine learning-based autonomous models. In addition, AF has a direct impact on the skin hydration level and, hence, can be used as a measure for detection. In this paper, we present an independent review along with a comparative analysis of the state-of-the-art techniques proposed for AF detection using ECG and skin hydration levels. This paper also highlights the effects of AF on skin hydration level that is missing in most of the previous studies.


Stroke ◽  
2001 ◽  
Vol 32 (suppl_1) ◽  
pp. 328-328
Author(s):  
David S Nilasena ◽  
Timothy F Kresowik ◽  
Anton F Piskac ◽  
Rebecca A Hemann ◽  
Marian A Brenton ◽  
...  

66 Background: The National Stroke Project is a HCFA initiative to improve stroke related hospital care for Medicare beneficiaries. As part of the evaluation of these efforts, HCFA is measuring performance on a set of quality indicators at the state and national levels. We report the baseline results for a key quality indicator for this project: warfarin at discharge for patients with atrial fibrillation (AF). Methods: Project data were abstracted from a national sample of Medicare inpatient charts with a principal or secondary diagnosis of AF (ICD-9-CM 427.31) and discharged between 4/98 and 3/99. All U.S. states, the District of Columbia, and Puerto Rico were sampled using a systematic random approach. Eligible patients were required to have physician confirmation of AF during the hospitalization and at discharge, or intermittent AF. The main outcome measure was a prescription or physician documented plan for warfarin at discharge. Results: Of 38,925 cases reviewed, 12,303 met the inclusion criteria. Many of the cases (38.3%) were excluded due to a history or current finding of hemorrhage. Nationwide, 6,633 (unadjusted rate, 53.9%) patients were prescribed warfarin at discharge or had a plan to start warfarin after discharge. The state-specific rates ranged from 30.7% to 65.3%. Univariate analyses showed that warfarin was prescribed less frequently (p<0.002) for adults 85 years of age and older (rate=39.9%, OR=0.47, 95% CI=0.43–0.51) and women (rate=52.0%, OR=0.83, 95% CI=0.78–0.90). African-Americans (rate=47.2%, OR=0.76 95% CI=0.63–0.90) and Asians (n=108, rate=37.0%, OR=0.50, 95% CI=0.34–0.74) were also found to have lower warfarin therapy rates. Conclusions: The results from this large national sample confirm the findings from other reports that there is substantial under-utilization of warfarin therapy for stroke prevention among Medicare patients with AF. This is particularly true for demographic subgroups at high risk for stroke. Quality improvement efforts are currently underway through HCFA’s National Stroke Project (AF topic) to increase warfarin use in appropriate AF patients.


2013 ◽  
Vol 28 (2) ◽  
pp. 170-180 ◽  
Author(s):  
Niv Ad ◽  
Linda Henry ◽  
Paul Massimiano ◽  
Grace Pritchard ◽  
Sari D. Holmes

EP Europace ◽  
2013 ◽  
Vol 15 (suppl_1) ◽  
pp. i35-i39 ◽  
Author(s):  
Renato Pietro Ricci

Sign in / Sign up

Export Citation Format

Share Document